Literature DB >> 6194882

Neurotoxicity of interferon.

K Mattson, A Niiranen, M Iivanainen, M Färkkilä, L Bergström, L R Holsti, H L Kauppinen, K Cantell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6194882

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  14 in total

1.  Interferon-induced organic mental disorders associated with unsuspected pre-existing neurologic abnormalities.

Authors:  F Adams; F Fernandez; G Mavligit
Journal:  J Neurooncol       Date:  1988-12       Impact factor: 4.130

Review 2.  Interferons, a group of multiple lymphokines.

Authors:  H Kirchner
Journal:  Springer Semin Immunopathol       Date:  1984

3.  Involvement of central opioid systems in human interferon-alpha induced immobility in the mouse forced swimming test.

Authors:  M Makino; Y Kitano; C Komiyama; M Hirohashi; K Takasuna
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

4.  Acute third cranial nerve ophthalmoplegia: possible pathogenesis from alpha-II-interferon treatment.

Authors:  L Pacifici; F Passarelli; G Papa; L Cannone; P M Rossini
Journal:  Ital J Neurol Sci       Date:  1993-10

5.  Common emergencies in cancer medicine: infectious and treatment-related syndromes, Part II.

Authors:  C R Thomas; K J Stelzer; J G Douglas; W J Koh; L V Wood; R Panicker
Journal:  J Natl Med Assoc       Date:  1994-11       Impact factor: 1.798

6.  Human leukocyte alpha interferon-induced transient neurotoxicity in children.

Authors:  J A Katz; D H Mahoney; C P Steuber; D J Fernbach
Journal:  Invest New Drugs       Date:  1988-06       Impact factor: 3.850

7.  Ocular pseudo-myasthenic reaction induced by interferon in an AIDS patient.

Authors:  R R Riedel; A Schmitt; A Hartmann
Journal:  Klin Wochenschr       Date:  1991-12-11

Review 8.  Interferons, signal transduction pathways, and the central nervous system.

Authors:  Shreeram C Nallar; Dhan V Kalvakolanu
Journal:  J Interferon Cytokine Res       Date:  2014-08       Impact factor: 2.607

9.  Clinical and immunological evaluation of 20 patients with advanced colorectal cancer treated with high dose recombinant leukocyte interferon-alpha A (rIFN alpha A).

Authors:  A M Eggermont; W Weimar; B Tank; A M Dekkers-Bijma; R L Marquet; J S Lameris; D L Westbroek; J Jeekel
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

Review 10.  Clinical toxicity of the interferons.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1994-02       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.